Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene.
about
Human uroporphyrinogen III synthase: molecular cloning, nucleotide sequence, and expression of a full-length cDNAFamilial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles.Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyriaAn isoform-specific mutation in the protein 4.1 gene results in hereditary elliptocytosis and complete deficiency of protein 4.1 in erythrocytes but not in nonerythroid cellsA point mutation G----A in exon 12 of the porphobilinogen deaminase gene results in exon skipping and is responsible for acute intermittent porphyriaErythroid heme biosynthesis and its disordersMolecular evolution of multiple-level control of heme biosynthesis pathway in animal kingdomStructure of human porphobilinogen deaminase at 2.8 A: the molecular basis of acute intermittent porphyriaMutations in acute intermittent porphyria detected by ELISA measurement of porphobilinogen deaminasePorphobilinogen deaminase in human erythrocytes: purification of two forms with apparent molecular weights of 40 kDa and 42 kDaFeline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations.Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.Heterogeneity of familial porphyria cutanea tarda.The little imitator--porphyria: a neuropsychiatric disorderInactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.Tissue-specific splicing mutation in acute intermittent porphyria.Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.Biochemical characterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement.Congenital erythropoietic porphyria: advances in pathogenesis and treatment.Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria.One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoansRegulation of erythroid cell-specific gene expression during erythropoiesis.Identification and expression of mutations in the hydroxymethylbilane synthase gene causing acute intermittent porphyria (AIP).Synthesis, delivery and regulation of eukaryotic heme and Fe-S cluster cofactors.Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression.Molecular genetics of porphyrias.Uroporphyrinogen III synthase. An alternative promoter controls erythroid-specific expression in the murine gene.Use of proteinase K for RT-PCR of cytokine mRNA in formalin fixed tissue.Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma.Molecular genetics of disorders of haem biosynthesisHypoxia decreases the expression of the two enzymes responsible for producing linear and cyclic tetrapyrroles in the heme biosynthetic pathway.Rat porphobilinogen deaminase cDNA: nucleotide sequence of the erythropoietic form.The three-dimensional structures of mutants of porphobilinogen deaminase: toward an understanding of the structural basis of acute intermittent porphyria.Insertion of Alu element responsible for acute intermittent porphyria.Review: molecular pathogenesis of hepatic acute porphyrias.Expression of ferrochelatase mRNA in erythroid and non-erythroid cells.A simple rapid purification scheme for hydroxymethylbilane synthase from human erythrocytes.Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria.Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene.
P2860
Q24297051-7004B879-A3EF-40D5-B67D-5A9238C97AD4Q24539508-FD53CAD8-BEA3-416A-A356-052CF610746FQ24618191-417775B1-D79B-4402-8B1D-89869F187A1FQ24618310-DA417629-CA98-44AE-BB88-2A7C11C2BF87Q24635350-807D87BF-EC99-43C7-8360-5BF150671D93Q27008081-0710B4DF-47CC-46FA-B62E-1727A0E62942Q27329732-9D3A31BE-2B1C-4B97-B4AA-1C598760F7A4Q27653713-7CA071F8-A5EC-40A2-A585-871131F5FD90Q28263415-0A3B12B4-2280-46AD-8E1E-D3698EC62EFBQ28263720-FF664141-0F2B-40E9-9AAC-FA0CEFE54287Q33594209-93833BC4-32E9-4A5B-9E93-0426C7E2B1BAQ33648180-02518A96-FB4A-473B-B7F3-64AE949CFF24Q33681928-5431F11E-AEF9-4752-8775-4EDA4CB48953Q33735657-ADD854A8-FDB6-4FCC-98CC-4F01C2696BF3Q33784777-FD04D3B8-C08B-4F24-A45D-B4A09A61FF29Q33832705-7C721392-84E3-42C2-B9B9-CF99CEB61535Q33836036-277C33A1-9C55-49FE-9674-6D11BAE08321Q34464770-7700D229-094C-4109-9658-0C404A6847A8Q34520894-0D5F384B-B657-4797-8E86-131AC5FBED25Q34680808-3C9A2430-05EA-4D54-903C-553253D96CB4Q35250368-6899C01D-B7FD-4AD8-9F25-558D47D22D0DQ36143730-B8A87335-DFAF-40C4-8DA6-E91A4028AFC5Q36290248-BC101802-A45F-4DC4-8483-F145F1CBB817Q36438542-1088A3C8-A3A4-47DC-B27E-F0D6997A9ACFQ36667724-46137EF0-A508-476D-8BBD-3198A22D7FEEQ37479183-2E3634E9-DB07-4BF7-AE05-F6244C8F9706Q37782849-75D944FE-FFD1-4AF6-A08B-0B4902C87186Q38316319-2298E12F-4984-494C-BCDD-CD7D8D4841E3Q38476456-7BEFDABC-02CE-4A82-BDC0-7CA7C3F5ECB0Q38799083-DBF9CEE6-66C5-45C9-9A8C-0D002AC21FC9Q39624267-F75365B9-2826-46A8-A72F-B946F3820829Q39914085-66E677E0-D5E0-432B-93ED-4EC846A317DDQ40545161-6A36A61F-0811-489B-9BC4-6EA4543FEF62Q40588503-CD482749-4686-4057-B7C3-8BDB223ACD51Q40941569-3032BA7B-520E-4A31-8AFE-9BCF2F2FE967Q41294557-795BBC2B-FA14-4E42-879C-B0252C55E7B5Q41808380-4949E6CB-AA2B-414A-B13E-8AF273DA75BEQ41861547-430506C0-A3A8-4087-ADE2-D3A7A826E9DAQ42546208-6DC00DB7-FF11-46B6-9E54-61CB87603AC2Q44173479-6ABBD850-2ACD-4B0D-A546-F8AB262DED6A
P2860
Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Tissue-specific expression of ...... isoenzymes from a single gene.
@en
Tissue-specific expression of ...... isoenzymes from a single gene.
@nl
type
label
Tissue-specific expression of ...... isoenzymes from a single gene.
@en
Tissue-specific expression of ...... isoenzymes from a single gene.
@nl
prefLabel
Tissue-specific expression of ...... isoenzymes from a single gene.
@en
Tissue-specific expression of ...... isoenzymes from a single gene.
@nl
P2093
P2860
P1433
P1476
Tissue-specific expression of ...... isoenzymes from a single gene.
@en
P2093
B Grandchamp
C Beaumont
H De Verneuil
S Chretien
Y Nordmann
P2860
P304
P356
10.1111/J.1432-1033.1987.TB10548.X
P407
P577
1987-01-01T00:00:00Z